Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Michigan for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Michigan only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Michigan (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Joel Miller (NPI 1720016215)

Field	Value
Entity Type	Individual
Organization	Joel Miller
Address	29201 Telegraph Rd
City	Southfield
State	MI
ZIP	48034
Taxonomy	Ophthalmology Physician
NPI Enumerated	June 30, 2006

Payer Source	Total Paid
Medicare	$1.4M
Medicaid	$0

Key Findings

This provider is highly focused on intravitreal injection therapies and retina-focused diagnostics: the largest revenue line is J0178 (aflibercept) accounting for $664.1K and 46.0% of Medicare revenue, supplemented by J2777 (faricimab) at $343K (23.7%) and 67028 (isolated intravitreal injection procedure) at $99K (6.9%). The code mix (drug injections plus retinal imaging and laser codes) is consistent with an ophthalmology practice that primarily delivers anti-VEGF biologic therapies and retina clinic services rather than broad multispecialty outpatient care.

Revenue is heavily concentrated in a small set of procedures: the precomputed top 3 Medicare codes represent 76.6% of this provider’s total Medicare revenue, indicating that a few high-cost drug administrations and associated procedural codes drive the majority of billed Medicare dollars. This concentration suggests business sensitivity to changes in reimbursement or utilization for those specific agents and services.

This provider is effectively single-payer in the available dataset: total Medicare revenue is $1.4M while there is no Medicaid billing on file. Analysts should treat this profile as Medicare-dominant for lifetime billing activity and consider that Medicaid mix will not meaningfully impact payer-negotiation dynamics or access patterns for this NPI.

Competitive standing versus national Medicare peers is mixed by code: for J0178 the provider ranks #1310 of 3204 (59th percentile), and for J2777 ranks #887 of 2039 (57th percentile), both described as typical or unremarkable volumes nationally — indicating modest but routine participation in high-cost intravitreal drug administration. By contrast, routine evaluation-and-management and certain diagnostics show markedly elevated national standings: 99213 ranks in the 99th percentile (extreme outlier) and 92134 ranks in the 96th percentile (notably above typical), indicating unusually high volume of office visits and retinal OCT imaging relative to peers.

Several E/M and diagnostic codes are statistical outliers in national comparisons: 99213 is labeled an "extreme outlier" at the 99th percentile and 92134 is "notably above typical" at the 96th percentile, implying this clinician sees a very high number of established-patient visits and performs a large volume of retinal imaging compared with national peers. These high encounter and imaging volumes align with the therapy-heavy revenue mix and suggest a busy clinic workflow centered on follow-up visits for retinal disease management.

Other procedure and drug codes show routine national standing: 67028 (intravitreal injection procedure) ranks in the 69th percentile, J2778 (ranibizumab) in the 18th percentile, and multiple ancillary tests (92235 fluorescein angiography, J3590 unclassified biologics) fall in mid-to-high percentiles described as typical or unremarkable. This pattern indicates selective use of specific biologics and standard ancillary testing consistent with retina specialty practice rather than unusually broad procedural scope.

Tenure data show this NPI was enumerated on 2006-06-30 (approximately 20 years ago), supporting that the provider has an established practice history. That duration combined with high volumes of established-patient visits and retinal imaging suggests a mature retina clinic likely with an ongoing follow-up population.

Because Medicaid activity is absent, any competitive analysis or network negotiations should focus on Medicare-based benchmarks and peer percentiles presented here. The absence of Medicaid billing means the provider does not appear to participate in Medicaid programs under this NPI, which affects payer mix considerations and potential access for dual-eligible populations.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

19 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J0178	Injection, aflibercept, 1 mg	980	$680	$664.1K
J2777	Injection, faricimab‑svoa, 0.1 mg	11,830	$30	$343K
67028	The provider injects a medication into the vitreous chamber of the eye as an isolated procedure or a separate procedure unrelated to any other procedure being performed on the eye.	1,060	$90	$99K
99213	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the…	990	$70	$66K
92134	The provider performs computerized diagnostic imaging of the retina in the posterior segment (back part) of the eye, interprets the data, and provides a report. The service may be on one or both eyes.	2,050	$30	$61.5K
99214	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the…	630	$90	$57.5K
J2778	Injection, ranibizumab, 0.1 mg	290	$180	$52.7K
92235	The provider uses a special dye, fluorescein that causes the blood vessels in the one or both eyes to stand out in photographic images taken with the use of multiframe timing, or serial images, taken…	270	$110	$28.5K
J3590	Unclassified biologics	340	$70	$24.8K
99204	The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the provider…	170	$130	$22K

Showing 1–10 of 19

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 19 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Michigan Distribution

Joel Miller — 5 of 19 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Michigan

Full comparison — all codes billed, vs. state median

19 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J0178	39	110	680	$690	$630.2K
J2777	20	60	7,200	$30	$321K
J2778	41	50	730	$180	$240.5K
67028	34	160	440	$90	$57.6K
J3590	20	80	140	$80	$19.6K
92014	815	1,080	100	$80	$14.8K
99214	467	15,470	80	$80	$11.4K
92235	5	100	40	$100	$7.8K
92134	22	820	60	$30	$7.1K
67228	17	30	30	$250	$6.7K

Showing 1–10 of 19

Related Providers

Other providers that share a Tax Identification Number (TIN) with Joel Miller, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Michael Ober	MI	Ophthalmology Physician	$1.8M	$0
Darrin Levin	MI	Ophthalmology Physician	$1.5M	$0
Randee Watson	MI	Ophthalmology Physician	$1.3M	$0
Nathan Cutler	MI	Ophthalmology Physician	$1.2M	$0
Susan Malinowski	MI	Ophthalmology Physician	$1.1M	$0

Nearby Providers

Other providers in the same ZIP code as Joel Miller, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Pro Care Unlimited, LLC	MI	Home Health Agency	$0	$216M
Coordinated Community Living	MI	Home Health Agency	$0	$85.8M
Vhs Physicians Of Michigan	MI	Internal Medicine Physician	$0	$73.9M
Angels' Place	MI	Intellectual and/or Developmental Disabilities Community Based Residential Treatment Facility	$0	$18.1M
North West Labs, Inc.	MI	Clinical Medical Laboratory	$1.4M	$10.9M
Great Lakes Surgical Center LLC	MI	Ambulatory Surgical Clinic/Center	$82.6K	$4M
City Of Southfield	MI	Ambulance	$845.3K	$1.8M
Biogenetics Laboratories, Inc.	MI	Clinical Medical Laboratory	$648.4K	$1.9M
Robert Scribner	MI	Gerontology Nurse Practitioner	$1.5M	$0
Mps Asc Ventures Inkster, LLC	MI	Ambulatory Surgical Clinic/Center	$1.3M	$0

Joel Miller — Billing Profile & Reimbursement Data

Sign up for Joel Miller — Billing Profile & Reimbursement Data policy alerts

Joel Miller — Billing Profile & Reimbursement Data

Sign up for Joel Miller — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References